This statistic displays an annual cost comparison of multiple sclerosis (MS) drugs in the United States based on their cost during their approval date and their December 2013 cost. Avonex cost on average 8,723 U.S. dollars per year in 1996 and had increased to a cost of 62,394 U.S. dollars as of December 2013.
Multiple sclerosis drug annual costs in the U.S. at approval date and in 2013
(in U.S. dollars)
MS: multiple sclerosis
* Interfereon-ß-1b is marketed as Betaseron (Bayer) and Extavia (Novartis).
** Natalizumab was withdrawn from the market in February 2005 to evaluate progressive multifocal leukoencephalopathy risk and was reintroduced in June 2006.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Neurology. (April 24, 2015). Multiple sclerosis drug annual costs in the U.S. at approval date and in 2013 (in U.S. dollars) [Graph]. In Statista. Retrieved November 09, 2024, from https://www.statista.com/statistics/448244/approval-date-and-2013-annual-ms-drug-costs-comparison-in-the-us/
Neurology. "Multiple sclerosis drug annual costs in the U.S. at approval date and in 2013 (in U.S. dollars)." Chart. April 24, 2015. Statista. Accessed November 09, 2024. https://www.statista.com/statistics/448244/approval-date-and-2013-annual-ms-drug-costs-comparison-in-the-us/
Neurology. (2015). Multiple sclerosis drug annual costs in the U.S. at approval date and in 2013 (in U.S. dollars). Statista. Statista Inc.. Accessed: November 09, 2024. https://www.statista.com/statistics/448244/approval-date-and-2013-annual-ms-drug-costs-comparison-in-the-us/
Neurology. "Multiple Sclerosis Drug Annual Costs in The U.S. at Approval Date and in 2013 (in U.S. Dollars)." Statista, Statista Inc., 24 Apr 2015, https://www.statista.com/statistics/448244/approval-date-and-2013-annual-ms-drug-costs-comparison-in-the-us/
Neurology, Multiple sclerosis drug annual costs in the U.S. at approval date and in 2013 (in U.S. dollars) Statista, https://www.statista.com/statistics/448244/approval-date-and-2013-annual-ms-drug-costs-comparison-in-the-us/ (last visited November 09, 2024)
Multiple sclerosis drug annual costs in the U.S. at approval date and in 2013 (in U.S. dollars) [Graph], Neurology, April 24, 2015. [Online]. Available: https://www.statista.com/statistics/448244/approval-date-and-2013-annual-ms-drug-costs-comparison-in-the-us/
